Inhalation

INH1026

Issue link: https://www.e-digitaleditions.com/i/1546950

Contents of this Issue

Navigation

Page 23 of 43

22 OctOber 2026 Inhalation Inhaled and nasal drug delivery systems RxPack is a global leader in pharmaceutical dis- pensing solutions and inhaled nasal drug delivery systems. Specializing in pMDIs, RxPack offers a comprehensive valve portfolio for solutions and sus- pensions, for single or double-stage filling. e com- pany supports its customers in navigating complex product development changes and the transition from the existing propellants to the new HFA-152a and HFO-1234ze(E) gases. RxPack partners with Coster's Machinery Division for the provision of lab- scale and high-speed filling lines. RxPack S.r.l. Italy: +39 034118960 info@rxpack.it www.rxpack.eu Nasal formulation development and manufacturing Renaissance Lakewood offers contract development and manufacturing for nasal sprays. We can support all stages of projects, from formulation development through commercial manufacturing. With over 20 years of experience, our team can support a wide range of development activities including formulation development/optimization, spray method develop- ment, device selection, clinical trial material, process development and stability studies. In addition, we can support a wide range of nasal spray devices, includ- ing unit-dose, bi-dose and multi-dose (preserved and non-preserved formulations). Renaissance Lakewood US: +1 732 367-9000 www.renpharm.com Semi- or fully automated testing systems Not only can you accurately control test variables such as air flow, firing force, speed and distance for dose wasting and collection, but each part of your semi- or fully automated testing system can provide the traceable data needed for quality and compli- ance. Your 21 CFR Part 11 compliant data capture, storage and retrieval are available through our user- friendly Relovex ® software. And your testing system can be installed as a stand-alone unit or integrated into Astech's full range of automated testing systems. Astech Projects UK: +44 1928 571797 www.astechprojects.co.uk Dry powder inhalation capsule portfolio Lonza's Capsugel ® Zephyr™ dry powder inhalation (DPI) capsule portfolio is a comprehensive capsule product offering, featuring customized DPI capsules and dedicated equipment in place for efficient, phase- appropriate capsule filling. e Zephyr DPI portfolio addresses the need for highly customized solutions for pulmonary route delivery methods and is supported by Lonza's inhalation and drug development and par- ticle engineering capabilities. is integrated product and service offering can enable consistent and optimal release performance for inhalation drugs. Lonza Capsules & Health Ingredients US: +1 888 783-6361 www.capsugel.com

Articles in this issue

Links on this page

view archives of Inhalation - INH1026